Children's Hospital Colorado completes first dual heart and liver transplant

An 11-year-old girl named Gracie Greenlaw has received a groundbreaking dual heart and liver transplant at Children's Hospital Colorado, marking the hospital's first such procedure. Born with hypoplastic left heart syndrome, Gracie underwent the 16-hour surgery after years of medical management for her condition. Seven months later, she is back home and attending school.

Children's Hospital Colorado achieved a medical milestone by performing its inaugural dual heart and liver transplant on 11-year-old Gracie Greenlaw. The procedure, which lasted 16 hours, involved coordination among dozens of specialists from 25 multidisciplinary teams. Nationwide, only 38 pediatric patients have undergone this combined transplant before.

Gracie was born with hypoplastic left heart syndrome (HLHS), a congenital defect where the heart develops with just one functional pumping chamber. By age three, she had endured three major operations—the Norwood, Glenn, and Fontan procedures—to improve blood circulation. These interventions, while life-extending, often lead to complications like liver failure, which Gracie developed alongside plastic bronchitis.

To manage such cases, the hospital launched its Fontan Multidisciplinary Clinic in 2016 within the Single Ventricle Program. This initiative provides integrated care for patients with HLHS and similar conditions. Gracie's team, including cardiologist Dr. Kathleen Simpson and hepatologist Dr. Dania Brigham, monitored her closely. As her liver failure progressed over the past year, the experts determined a dual transplant offered the best path forward. She joined the transplant waitlist in April.

Less than a month later, donor organs became available thanks to another family's donation. The surgery prioritized the heart, which has a limited viability window. Dr. Matthew Stone, surgical director of the Pediatric Heart Transplant Program, and congenital heart surgeon Dr. Emily Downs completed the nine-hour heart transplant. Meanwhile, the donor liver was preserved using a TransMedics Organ Care System, mimicking normal liver function. Dr. Megan Adams and transplant surgeon Dr. Kendra Conzen then handled the seven-hour liver transplant, with anesthesiology teams ensuring stability throughout.

"Performing Children's Colorado's first-ever heart and liver dual organ transplant is an amazing accomplishment for our Pediatric Transplant Program," said Dr. Adams, surgical director of the Pediatric Liver and Kidney Transplant Programs. The effort reflects years of preparation and hospital support.

Gracie's recovery progressed well; she left the cardiac care unit after over a month and, seven months post-surgery, attends monthly check-ups while resuming normal activities with her dogs. Although she will require a future heart transplant, her new liver is expected to endure lifelong. Dr. Duncan Wilcox, the hospital's surgeon in chief, highlighted the procedure as evidence of their expertise in complex pediatric care.

Relaterede artikler

Illustration depicting Children's Hospital Colorado amid federal probe and subpoena battle over youth gender-affirming care records.
Billede genereret af AI

HHS refers Children’s Hospital Colorado to inspector general as hospital fights DOJ subpoena over youth gender-affirming care records

Rapporteret af AI Billede genereret af AI Faktatjekket

The U.S. Department of Health and Human Services said it has referred Children’s Hospital Colorado to its inspector general over what it described as noncompliance with newly announced federal standards targeting certain gender-related medical interventions for minors. The hospital is separately asking a federal court to block a Justice Department subpoena seeking records tied to its care for transgender adolescents, as a coalition of Democratic-led states challenges the federal initiative in court.

The Gregorio Marañón University Hospital has successfully performed Europe's first partial heart transplant on a seven-month-old baby. Mariami is recovering well after leaving Intensive Care just two days post-surgery. This breakthrough, endorsed by transplant authorities, combines pioneering techniques and could transform treatments for children with heart defects.

Rapporteret af AI

Hilario, a 3-year-old boy who has been on dialysis since birth, will receive a kidney transplant from his mother in the coming days. The surgery aims to improve his quality of life after several previous attempts failed. “His grit, joy, and will to live do not allow us to lower our arms,” said his mother Marina.

A 58-year-old fetal medicine consultant from Bengaluru has successfully donated her kidney to an unrelated woman in her 50s, following a legal battle that reached the Karnataka High Court. Thankam Subramonian, inspired by organ donation talks since 2014, overcame family concerns and institutional hurdles to become an altruistic donor. The court approved her request in November 2025, highlighting the rarity of such cases.

Rapporteret af AI

Bijou Phillips, the 45-year-old model, has been hospitalized in Los Angeles and is on dialysis while waiting for a kidney transplant. Her representative confirmed she is in stable condition at UCLA Health, though time is critical. Phillips shared her situation on Instagram, seeking living donors.

The mayor of Providencia, Jaime Bellolio, led a traditional Christmas visit to the Luis Calvo Mackenna Hospital, where 145 children, girls, and adolescents spent the holidays hospitalized. The initiative included storytelling and gift delivery to brighten their special day. The hospital director, Michel Roger, highlighted the importance of bringing Christmas magic to all patients.

Rapporteret af AI Faktatjekket

Stanford Medicine researchers have developed a combined blood stem cell and pancreatic islet cell transplant that, in mice, either prevents or cures type 1 diabetes using tissue from immunologically mismatched donors. The approach creates a hybrid immune system that halts autoimmune attacks without immunosuppressive drugs, and relies on tools already in clinical use, suggesting human trials may be feasible.

 

 

 

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis